The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elsawa, S. F.
Right arrow Articles by Bost, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elsawa, S. F.
Right arrow Articles by Bost, K. L.
The Journal of Immunology, 2004, 172: 516-524.
Copyright © 2004 by The American Association of Immunologists

Murine {gamma}-Herpesvirus-68-Induced IL-12 Contributes to the Control of Latent Viral Burden, but Also Contributes to Viral-Mediated Leukocytosis 1

Sherine F. Elsawa and Kenneth L. Bost2

Department of Biology, University of North Carolina, Charlotte, NC 28223

Early IFN-{alpha}/{beta} production, followed by the development of a viral-specific CTL response, are critical factors in limiting the level of murine {gamma}-herpesvirus-68 ({gamma}HV-68) infection. Development of a long-lived CTL response requires T cell help, and these CTLs most likely function to limit the extent of infection following reactivation. The importance of IL-12 in the development and/or activity of Th1 cells and CTLs is well documented, and we investigated the kinetics and magnitude of {gamma}HV-68-induced IL-12 production. Following intranasal infection, IL-12 and IL-23 mRNA expression was up-regulated in lung and spleen and lung, respectively, followed by increased levels of IL-12p40 in lung homogenates and sera. Exposure of cultured macrophages or dendritic cells to {gamma}HV-68 induced secretion of IL-12, suggesting that these cells might be responsible for IL-12 production in vivo. {gamma}HV-68 infection of mice made genetically deficient in IL-12p40 expression (IL-12p40-/-) resulted in a leukocytosis and splenomegaly that was significantly less than that observed in syngeneic C57BL/6 mice. IL-12p40-/- mice showed increased levels of infectious virus in the lung, but only at day 9 postinfection. Increased levels of latent virus in the spleen at day 15 postinfection were also observed in IL-12p40-/- mice when compared with syngeneic C57BL/6 mice. An overall reduction in {gamma}HV-68-induced IFN-{gamma} production was observed in IL-12p40-/- mice, suggesting that most of the viral-induced IFN-{gamma} in C57BL/6 mice was IL-12 dependent. Taken together, these results suggest that {gamma}HV-68-induced IL-12 contributes to the pathophysiology of viral infection while also functioning to limit viral burden.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Guggemoos, D. Hangel, S. Hamm, A. Heit, S. Bauer, and H. Adler
TLR9 Contributes to Antiviral Immunity during Gammaherpesvirus Infection
J. Immunol., January 1, 2008; 180(1): 438 - 443.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. C. Reading, P. G. Whitney, D. P. Barr, M. Wojtasiak, J. D. Mintern, J. Waithman, and A. G. Brooks
IL-18, but not IL-12, Regulates NK Cell Activity following Intranasal Herpes Simplex Virus Type 1 Infection
J. Immunol., September 1, 2007; 179(5): 3214 - 3221.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Gasper-Smith, I. Marriott, and K. L. Bost
Murine {gamma}-Herpesvirus 68 Limits Naturally Occurring CD4+CD25+ T Regulatory Cell Activity following Infection
J. Immunol., October 1, 2006; 177(7): 4670 - 4678.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.